论文部分内容阅读
目的分析阿托伐他汀联合曲美他嗪治疗冠心病的临床疗效。方法 100例冠心病患者,按照治疗方法的不同分成对照组(选择曲美他嗪治疗)和实验组(选择阿托伐他汀联合曲美他嗪治疗),各50例。对两组患者的临床疗效进行观察比较。结果实验组总有效率92.0%高于对照组76.0%,差异具有统计学意义(χ2=4.762,P<0.05)。实验组心绞痛持续时间短于对照组,发作次数少于对照组,差异均具有统计学意义(t=6.128、13.156,P<0.05)。结论在对冠心病患者进行治疗时,阿托伐他汀联合曲美他嗪治疗具有比较显著的临床疗效,值得临床推广。
Objective To analyze the clinical efficacy of atorvastatin combined with trimetazidine in the treatment of coronary heart disease. Methods 100 patients with coronary heart disease were divided into control group (treated with trimetazidine) and experimental group (treated with atorvastatin combined with trimetazidine) according to different treatment methods, 50 cases in each. The clinical efficacy of two groups of patients were observed and compared. Results The total effective rate in the experimental group was 92.0% higher than that in the control group (76.0%), the difference was statistically significant (χ2 = 4.762, P <0.05). The duration of angina pectoris in the experimental group was shorter than that in the control group, and the number of seizures was less than that in the control group. The differences were statistically significant (t = 6.128, 13.156, P <0.05). Conclusions Atorvastatin combined with trimetazidine has a significant clinical effect in the treatment of patients with coronary heart disease, and is worthy of clinical promotion.